ChemAbout

ChemAbout is a B2B platform where chemical buyers and suppliers discover each other.

Post a purchase requestList your products (for suppliers)
© 2026 ChemAbout
Compound Index|Demand Board|Insights|Exhibitions|Compliance|Help Center|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/Pharmaceutical Intermediate/Fmoc-D-Aspartic acid beta-tert-butyl ester
C23H25NO6
411.4 g/mol
Pharmaceutical IntermediateWarning

4-tert-Butyl N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-D-aspartate

CAS112883-39-3EC802-374-8
Category
Pharmaceutical Intermediate
Compound Class
Peptide
Primary Use
Pharmaceutical Intermediate

This compound is a protected amino acid derivative used as an intermediate in peptide synthesis. It features a fluorenylmethoxycarbonyl (Fmoc) protecting group and tert-butyl ester protection on the side chain, which are commonly employed in solid-phase peptide chemistry.

Peptide synthesis intermediateLaboratory reagent for Fmoc-based solid-phase peptide synthesis

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing this compound?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→

Related Compounds

SimilarStructure SimilarSimilarity 0.77

(S)-2-Fmoc-aminohexanedioic acid 6-tert-butyl ester

CAS159751-47-0

pharmaceutical intermediate

SimilarStructure SimilarSimilarity 0.75

L-Fmoc-Aspartic acid alpha-tert-butyl ester

CAS129460-09-9

pharmaceutical intermediate

SimilarStructure SimilarSimilarity 0.73

Fmoc-O-tert-butyl-D-serine

CAS128107-47-1

pharmaceutical intermediate

ApplicationSame Use

Fmoc-D-Arginine

CAS130752-32-8

pharmaceutical intermediate

ApplicationSame Use

Fmoc-Glu(OtBu)-Phe-OH

CAS1122076-55-4

pharmaceutical intermediate

ApplicationSame Use

N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-4-[[[(4S)-hexahydro-2,6-dioxo-4-pyrimidinyl]carbonyl]amino]-L-phenylalanine

CAS1253282-31-3

pharmaceutical intermediate

ApplicationSame Use

N-Boc-N'-tosyl-L-arginine

CAS13836-37-8

pharmaceutical intermediate

ReferenceSame Category

2-Acetylamidomethyl-4-(4-fluorobenzyl)morpholine

CAS112913-94-7

pharmaceutical intermediate

Related Reading

Therapeutic Peptides in 2026: This Year's Breakthroughs

2026 has been a concentrated year for peptide therapeutics. Efficacy reached a new high in late-stage trials, the obesity field moved beyond the incretins to amylin, the oral route reached weight management, and peptide-guided radioligand therapy kept advancing — each point tied to a specific 2025–2026 result.

Read more

Safety Reference

Environmental Hazard
Environmental Hazard
Warning
H410Very toxic to aquatic life with long lasting effects
Identifiers
IUPAC Name

(2R)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-4-[(2-methylpropan-2-yl)oxy]-4-oxobutanoic acid

InChIKey

FODJWPHPWBKDON-LJQANCHMSA-N

SMILES

CC(C)(C)OC(=O)C[C@H](C(=O)O)NC(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13

Synonyms (18)
  • Fmoc-D-Asp(OtBu)-OH
  • Fmoc-D-Asp(tBu)-OH
  • Fmoc-DAsp(OtBu)

Sourcing this compound?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→